233 related articles for article (PubMed ID: 26121522)
1. A comparison between general rheumatologists and scleroderma experts with respect to following systemic sclerosis guidelines.
Reed J; Pope J
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S40-6. PubMed ID: 26121522
[TBL] [Abstract][Full Text] [Related]
2. Best practices in scleroderma: an analysis of practice variability in SSc centres within the Canadian Scleroderma Research Group (CSRG).
Harding S; Khimdas S; Bonner A; Baron M; Pope J;
Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S38-43. PubMed ID: 22691207
[TBL] [Abstract][Full Text] [Related]
3. Agreement with guidelines from a large database for management of systemic sclerosis: results from the Canadian Scleroderma Research Group.
Pope J; Harding S; Khimdas S; Bonner A; ; Baron M
J Rheumatol; 2012 Mar; 39(3):524-31. PubMed ID: 22247347
[TBL] [Abstract][Full Text] [Related]
4. Content of non-pharmacological care for systemic sclerosis and educational needs of European health professionals: a EUSHNet survey.
Willems LM; Redmond AC; Stamm TA; Boström C; Decuman S; Kennedy AT; Brozd J; Roškar S; Smith V; Vliet Vlieland TP; van den Ende CH
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S153-9. PubMed ID: 26339894
[TBL] [Abstract][Full Text] [Related]
5. Rheumatic diseases and pregnancy: a national survey about practice patterns among rheumatologists and obstetricians.
Fayad F; Ziade N; Karam GA; Ghaname W; Khamashta M
Clin Exp Rheumatol; 2018; 36(6):1014-1021. PubMed ID: 29846160
[TBL] [Abstract][Full Text] [Related]
6. Screening for pulmonary arterial hypertension in patients with scleroderma--a New Zealand perspective.
Ghosh SK; Corkill MM; Hart HH; Ng KP
N Z Med J; 2014 Aug; 127(1400):30-8. PubMed ID: 25145365
[TBL] [Abstract][Full Text] [Related]
7. Evidence-based management of systemic sclerosis: Navigating recommendations and guidelines.
Pellar RE; Pope JE
Semin Arthritis Rheum; 2017 Jun; 46(6):767-774. PubMed ID: 28088339
[TBL] [Abstract][Full Text] [Related]
8. Recognition of pulmonary hypertension in the rheumatology community: lessons from a Quality Enhancement Research Initiative.
Khanna D; Tan M; Furst DE; Hill NS; McLaughlin VV; Silver RM; Steen VD; Langer A; Seibold JR;
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-21-7. PubMed ID: 24295227
[TBL] [Abstract][Full Text] [Related]
9. Digital Sympathectomy in Patients With Scleroderma: An Overview of the Practice and Referral Patterns and Perceptions of Rheumatologists.
Chiou G; Crowe C; Suarez P; Chung L; Curtin C; Chang J
Ann Plast Surg; 2015 Dec; 75(6):637-43. PubMed ID: 26418780
[TBL] [Abstract][Full Text] [Related]
10. [Guidelines in rheumatology--how far along are we].
Huppertz HI
Z Rheumatol; 2005 Jun; 64(5):351-2. PubMed ID: 15965821
[No Abstract] [Full Text] [Related]
11. Survey of rheumatologists on the use of the Philippine Guidelines on the Screening for Tuberculosis prior to use of Biologic Agents.
Aquino-Villamin M; Tankeh-Torres S; Lichauco JJ
Int J Rheum Dis; 2016 Nov; 19(11):1126-1131. PubMed ID: 26545293
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary arterial hypertension screening practices in scleroderma patients among Canadian rheumatologists.
Quinn R; Koh D; Kelly D; Beattie KA; Larché MJ
J Scleroderma Relat Disord; 2020 Oct; 5(3):237-241. PubMed ID: 35382524
[TBL] [Abstract][Full Text] [Related]
13. Barriers to physician adherence to evidence-based monitoring guidelines in chronic myelogenous leukemia.
Goldberg SL; Akard LP; Dugan MJ; Faderl S; Pecora AL
J Oncol Pract; 2015 May; 11(3):e398-404. PubMed ID: 25758446
[TBL] [Abstract][Full Text] [Related]
14. Survey on management strategies of rheumatoid arthritis in Saudi Arabia: a Saudi Society for Rheumatology Initiative.
Omair MA; Omair MA; Halabi H
Int J Rheum Dis; 2017 Sep; 20(9):1185-1192. PubMed ID: 26354409
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study).
Wigley FM; Lima JA; Mayes M; McLain D; Chapin JL; Ward-Able C
Arthritis Rheum; 2005 Jul; 52(7):2125-32. PubMed ID: 15986394
[TBL] [Abstract][Full Text] [Related]
16. Expert agreement on EULAR/EUSTAR recommendations for the management of systemic sclerosis.
Walker KM; Pope J; ;
J Rheumatol; 2011 Jul; 38(7):1326-8. PubMed ID: 21459952
[TBL] [Abstract][Full Text] [Related]
17. Management of scleroderma in a New Zealand tertiary rheumatology centre: emphasis on pulmonary complications.
Ng K; Gow P
N Z Med J; 2007 May; 120(1254):U2537. PubMed ID: 17515941
[TBL] [Abstract][Full Text] [Related]
18. A Delphi exercise and cluster analysis to aid in the development of potential classification criteria for systemic sclerosis using SSc experts and databases.
Coulter C; Baron M; Pope JE
Clin Exp Rheumatol; 2013; 31(2 Suppl 76):24-30. PubMed ID: 23557780
[TBL] [Abstract][Full Text] [Related]
19. Treating rheumatoid arthritis to target: an Italian rheumatologists' survey on the acceptance of the treat-to-target recommendations.
Caporali R; Conti F; Covelli M; Govoni M; Salaffi F; Ventriglia G; Montecucco C
Clin Exp Rheumatol; 2014; 32(4):471-6. PubMed ID: 24960620
[TBL] [Abstract][Full Text] [Related]
20. Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohort.
Jung M; Bonner A; Hudson M; Baron M; Pope JE;
Scand J Rheumatol; 2014; 43(3):217-20. PubMed ID: 24650305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
